Skip to content

Comparison of Vonoprazan based therapy vs Standard Quadruple therapy for eradication of Helicobacter pylori.

Comparison of Vonoprazan based therapy vs Standard Quadruple therapy for eradication of Helicobacter pylori - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/074495
Enrollment
60
Registered
2024-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K296- Other gastritis

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

NBE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-80 years 2. All symptomatic patients with dyspepsia (ROME criteria 4)with proven h pylori on biopsy/ urea breath test/stool for h pylori ROME 4 CRITERIA 1. One or more of the following: 1. Bothersome postprandial fullness 2. Bothersome early satiation 3. Bothersome epigastric pain 4. Bothersome epigastric burning AND 2. No evidence of structural disease (including at upper endoscopy) that is likely to explain the symptoms (Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis)

Exclusion criteria

Exclusion criteria: Patients with the following findings will be excluded from the study 1. H/o gastric surgery such as partial gastrectomy 2. H/o allergy of drugs used in the study 3. Pregnant and lactating females 4. Alcohol or drug addiction 5. Lack of informed consent

Design outcomes

Primary

MeasureTime frame
Comparison of eradication rate of H. Pylori between the two regimens.Timepoint: 2 WEEKS

Secondary

MeasureTime frame
noneTimepoint: none

Countries

India

Contacts

Public ContactDr Ankush Bansal

Fortis Hospital,Mohali

ankushbansalab19@yahoo.com9988381946

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026